NRF1 and breast cancer: Therefore, we further explored the regulatory relationship between simvastatin and miRNAs in accordance with this idea, and found that simvastatin-ROS-NRF1 -miR-140-5p axis effectively inhibited breast cancer cells (Fig. 7E).